Advertisement

Polyethylene glycol–gum acacia-based multidrug delivery system for controlled delivery of anticancer drugs

  • V. O. Fasiku
  • B. A. Aderibigbe
  • E. R. Sadiku
  • Y. Lemmer
  • S. J. Owonubi
  • S. S. Ray
  • E. Mukwevho
Original Paper
  • 21 Downloads

Abstract

Breast cancer is a chronic disease that is characterized by an uncontrolled growth of abnormal cells from the breast tissue. It is one of the leading causes of mortality among women worldwide because of its early metastasis, aggressive behavior and resistance to the currently used anticancer drugs. Most of these drugs suffer from poor absorption and toxicity, and lack long-term efficaciousness because of drug resistance. Recently, polymeric thermosensitive hydrogels have emerged as excellent drug delivery systems for anticancer drugs with the potential to improve the overall therapeutic effect of the incorporated drug. In this current research, doxorubicin and curcumin were loaded into biodegradable PEG–gum acacia-based hydrogels. These hydrogels were pH-sensitive, biodegradable and non-toxic. The release mechanism of the drugs from the hydrogels was pH-dependent. In vitro cytotoxicity studies on MCF-7 cancer cell lines further confirmed that the incorporation of doxorubicin and curcumin into the hydrogels resulted in significant cytotoxic effect when compared to the free drugs, suggesting that these hydrogels are potential dual-drug delivery systems. The cytotoxic effect was dose- and time-dependent.

Graphical abstract

Keywords

Breast cancer Hydrogel Dual-drug delivery systems Curcumin Doxorubicin 

Notes

Acknowledgements

The financial supports from the National Research Foundation (NRF), the South Africa Medical Research Council (Self-Initiated Research) (MRC) and the North-West University (NWU), South Africa, toward this research are hereby acknowledged. The views and opinions expressed in this manuscript are those of the authors and not of NWU, MRC or NRF.

Compliance with ethical standards

Conflict of interest

The authors report no conflicts of interest.

References

  1. 1.
    Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics. CA Cancer J Clin 65:87–108CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Mondal J, Panigrahi AK, Khuda-Bukhsh AR (2014) Conventional chemotherapy: problems and scope for combined therapies with certain herbal products and dietary supplements. Austin J Mol Cell Biol 1(1):1–10Google Scholar
  3. 3.
    Asghar U, Meyer T (2012) Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? J Hepatol 56:686–695CrossRefPubMedGoogle Scholar
  4. 4.
    Greco F, Vicent MJ (2009) Combination therapy: opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 61:1203–1213CrossRefPubMedGoogle Scholar
  5. 5.
    Saraswathy M, Gong S (2013) Different strategies to overcome multidrug resistance in cancer. Biotechnol Adv 31:1397–1407CrossRefPubMedGoogle Scholar
  6. 6.
    Deepa K, Singha S, Panda T (2014) Doxorubicin nanoconjugates. J Nanosci Nanotechnol 14:892–904CrossRefPubMedGoogle Scholar
  7. 7.
    Wilken R, Veena MS, Wang MB et al (2011) Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10:12–15CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Misra R, Sahoo SK (2011) Coformulation of doxorubicin and curcumin in poly (d, l-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm 8:852–866CrossRefPubMedGoogle Scholar
  9. 9.
    Hui-TienLiu Yuan-SoonHo (2018) Anticancer effect of curcumin on breast cancer and stem cells. Food Sci Hum Wellness 7:134–137CrossRefGoogle Scholar
  10. 10.
    Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C (2015) Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res 35:645–651PubMedGoogle Scholar
  11. 11.
    Tuorkey MJ (2014) Curcumin a potent cancer preventive agent: mechanisms of cancer cell killing. Interv Med Appl Sci 6:139–146PubMedPubMedCentralGoogle Scholar
  12. 12.
    Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB (2011) Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics 21:440–446CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Patel AG, Kaufmann SH (2012) How does doxorubicin work? ELife 1:e00387CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Vashist A, Kaushik A, Vashist A et al (2016) Recent trends on hydrogel based drug delivery systems for infectious diseases. Biomater Sci 4:1535–1553CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Wu J, Zhao X, Wu D et al (2014) Development of a biocompatible and biodegradable hybrid hydrogel platform for sustained release of ionic drugs. J Mater Chem 2:6660–6668CrossRefGoogle Scholar
  16. 16.
    Sinha MK, Gao J, Stowell CE et al (2015) Synthesis and biocompatibility of a biodegradable and functionalizable thermo-sensitive hydrogel. Regen Biomater 2:177–185CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Wang Y, Chen L, Tan L, Zhao Q, Luo F, Wei Y, Qian Z (2014) PEG–PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. Biomaterials 35:6972–6985CrossRefPubMedGoogle Scholar
  18. 18.
    Seib FP, Tsurkan M, Freudenberg U, Kaplan DL, Werner C (2016) Heparin-modified polyethylene glycol microparticle aggregates for focal cancer chemotherapy. ACS Biomater Sci Eng 2:2287–2293CrossRefGoogle Scholar
  19. 19.
    Li M, Li H, Li X, Zhu H, Xu Z, Liu L, Ma J, Zhang M (2017) A bioinspired alginate-gum Arabic hydrogel with micro-/nanoscale structures for controlled drug release in chronic wound healing. ACS Appl Mater Interfaces 9:22160–22175CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Sarika PR, James NR (2015) Preparation and characterisation of gelatin–gum arabic aldehyde nanogels via inverse miniemulsion technique. Int Biol Macromol 76:181–187CrossRefGoogle Scholar
  21. 21.
    Giray S, Bal T, Kartal AM et al (2012) Controlled drug delivery through a novel PEG hydrogel encapsulated silica aerogel system. J Biomed Mater Res A 100:1307–1315CrossRefPubMedGoogle Scholar
  22. 22.
    Jiang G, Sun J, Ding F (2014) PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release. J Biomater Sci 25:241–256CrossRefGoogle Scholar
  23. 23.
    Singh B, Dhiman A (2017) Evaluation of gentamicin and lidocaine release profile from gum acacia-crosslinked-poly (2-hydroxyethylmethacrylate)-carbopol based hydrogels. Curr Drug Deliv 14:981–991PubMedGoogle Scholar
  24. 24.
    Shaikh MM, Lonikar MS, Lonikar SV (2014) Gum acacia-acrylic acid hydrogels: pH sensitive materials for drug delivery system. Asian J Res Chem 7:407–411Google Scholar
  25. 25.
    Huang GQ, Cheng LY, Xiao JX et al (2016) Genipin-crosslinked O-carboxymethyl chitosan–gum arabic coacervate as a pH-sensitive delivery system and microstructure characterization. J Biomater Appl 31:193–204CrossRefPubMedGoogle Scholar
  26. 26.
    Cao H, Yang Y, Shao ZZ (2015) Doxorubicin hydrochloride and curcumin loaded silk fibroin/hydroxypropylcellulose hydrogels for localized chemotherapy of cancer. J Control Release 213:e8–e152Google Scholar
  27. 27.
    Barui S, Saha S, Mondal G, Haseena S, Chaudhuri A (2014) Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature. Biomaterials 35:1643–1656CrossRefPubMedGoogle Scholar
  28. 28.
    Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X (2015) Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharm Biopharm 93:27–36CrossRefPubMedGoogle Scholar
  29. 29.
    Zhang Y, Yang C, Wang W, Liu J, Liu Q, Huang F, Chu L, Gao H, Li C, Kong D, Liu Q (2016) Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep 6:21225CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Varaprasad K, Vimala K, Ravindra S et al (2011) Development of sodium carboxymethyl cellulose-based poly (acrylamide-co-2acrylamido-2-methyl-1-propane sulfonic acid) hydrogels for in vitro drug release studies of ranitidine hydrochloride an anti-ulcer drug. Polym Plast Technol Eng 50:1199–1207CrossRefGoogle Scholar
  31. 31.
    Varaprasad K, Mohan YM, Ravindra S et al (2010) Hydrogel–silver nanoparticle composites: a new generation of antimicrobials. J Appl Polym Sci 115:1199–1207CrossRefGoogle Scholar
  32. 32.
    Aderibigbe B, Varaprasad K, Sadiku E et al (2015) Kinetic release studies of nitrogen-containing bisphosphonate from gum acacia crosslinked hydrogels. Int J Biol Macromol 73:115–123CrossRefPubMedGoogle Scholar
  33. 33.
    Holowka EP, Sujata KB (2014) Controlled release system. In: Bellomo EG (ed) Drug Delivery: materials design and clinical perspective. Springer, New YorkGoogle Scholar
  34. 34.
    Pawar H, Karde M, Mundle N et al (2014) Phytochemical evaluation and curcumin content determination of turmeric rhizomes collected from Bhandara District of Maharashtra (India). Med Chem 4:588–591CrossRefGoogle Scholar
  35. 35.
    Maheshkuma S, Reddy K, Goud P et al (2013) Formulation and characterization of doxorubicin hydrochloride liposomes by double emulsion method. Int Res J Pharm 4:197–201Google Scholar
  36. 36.
    Jayakumar R, Nair A, Rejinold NS et al (2012) Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells. Carbohydr Polym 87:2352–2356CrossRefGoogle Scholar
  37. 37.
    Rachmawati H, Edityaningrum CA, Mauludin R (2013) Molecular inclusion complex of curcumin–β-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel. AAPS PharmSciTech 14:1303–1312CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Shaikh MM, Lonikar MS, Lonikar SV (2014) Gum acacia-acrylic acid hydrogels: pH sensitive materials for drug delivery system. Asian J Res Chem 7:407–411Google Scholar
  39. 39.
    Zhang L, Jeong YI, Zheng S et al (2013) Biocompatible and pH-sensitive PEG hydrogels with degradable phosphoester and phosphoamide linkers end-capped with amine for controlled drug delivery. Polym Chem 4:1084–1094CrossRefGoogle Scholar
  40. 40.
    Garland MJ, Singh TR, Woolfson AD et al (2011) Electrically enhanced solute permeation across poly (ethylene glycol)–crosslinked poly (methyl vinyl ether-co-maleic acid) hydrogels: effect of hydrogel crosslink density and ionic conductivity. Int J Pharm 406:91–98CrossRefPubMedGoogle Scholar
  41. 41.
    Singh TR, Woolfson D, Donnelly R (2010) Solute permeation across poly (ethylene glycol)-crosslinked poly (methyl vinyl ether-co-maleic acid) hydrogels. J Pharm Pharmacol 62:829–837CrossRefGoogle Scholar
  42. 42.
    Khurma JR, Nand AV (2008) Temperature and pH sensitive hydrogels composed of chitosan and poly (ethylene glycol). Polym Bull 59:805–812CrossRefGoogle Scholar
  43. 43.
    Gupta NV, Shivakumar HG (2012) Investigation of swelling behavior and mechanical properties of a ph-sensitive superporous hydrogel composite. Iran J Pharm Res IJPR 11:481PubMedGoogle Scholar
  44. 44.
    Zhao Y, Su H, Fang L et al (2005) Superabsorbent hydrogels from poly (aspartic acid) with salt-, temperature-and pH-responsiveness properties. Polymer 46:5368–5376CrossRefGoogle Scholar
  45. 45.
    Yin OS, Ahmad I, Amin MC (2015) Synthesis of chemical cross-linked gelatin hydrogel reinforced with cellulose nanocrystals (CNC). In: AIP conference proceedings, Bandung, Indonesia, pp 375–380Google Scholar
  46. 46.
    Bajpai SK, Singh S (2006) Analysis of swelling behavior of poly (methacrylamide-co-methacrylic acid) hydrogels and effect of synthesis conditions on water uptake. React Funct Polym 66:431–440CrossRefGoogle Scholar
  47. 47.
    Kipcak AS, Ismail O, Doymaz I et al (2014) Modeling and investigation of the swelling kinetics of acrylamide-sodium acrylate hydrogel. J Chem.  https://doi.org/10.1155/2014/281063 CrossRefGoogle Scholar
  48. 48.
    Hu X, Wei W, Qi X et al (2015) Preparation and characterization of a novel pH-sensitive Salecan-g-poly (acrylic acid) hydrogel for controlled release of doxorubicin. J Mater Chem B 3:2685–2697CrossRefGoogle Scholar
  49. 49.
    Dadsetan M, Taylor KE, Yong C et al (2013) Controlled release of doxorubicin from pH-responsive microgels. Acta Biomater 9:5438–5446CrossRefPubMedGoogle Scholar
  50. 50.
    Tan SY, Ang CY, Mahmood A et al (2016) Doxorubicin-loaded metal–organic gels for pH and glutathione dual-responsive release. Chem NanoMat 2:504–508Google Scholar
  51. 51.
    Gerweck LE, Vijayappa S, Kozin S (2006) Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther 5:1275–1279CrossRefPubMedGoogle Scholar
  52. 52.
    Ko J, Park K, Kim YS et al (2007) Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy. J Control Release 123:109–115CrossRefPubMedGoogle Scholar
  53. 53.
    Zeighamian V, Darabi M, Akbarzadeh A et al (2016) PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells. Artifcells Nanomed Biotechnol 44:735–742CrossRefGoogle Scholar
  54. 54.
    Zhang Y, Yang C, Wang W et al (2016) Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep.  https://doi.org/10.1038/srep21225 CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Wei L, Cai C, Lin J et al (2009) Dual-drug delivery system based on hydrogel/micelle composites. Biomaterials 30:2606–2613CrossRefPubMedGoogle Scholar
  56. 56.
    Qiao X, Hu F, Hou D et al (2016) PEG assisted hydrothermal synthesis of hierarchical MoS 2 microspheres with excellent adsorption behavior. Mater Lett 169:241–245CrossRefGoogle Scholar
  57. 57.
    Anitha A, Deepagan V, Rani VD et al (2011) Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydr Polym 84:1158–1164CrossRefGoogle Scholar
  58. 58.
    Shaikh J, Ankola D, Beniwal V et al (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37:223–230CrossRefPubMedGoogle Scholar
  59. 59.
    Yallapu MM, Jaggi M, Chauhan SC (2010) β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces 79:113–125CrossRefPubMedGoogle Scholar
  60. 60.
    Chavis MA, You NH, Maeda R et al (2012) Cleavable self-organized thin films: block copolymers and brushes. Abstracts of Papers of the American Chemical Society, Amer Chem Soc 1155, 16th St, Nw, Washington, DC 20036, USAGoogle Scholar
  61. 61.
    She W, Luo K, Zhang C et al (2013) The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron–doxorubicin conjugates for cancer therapy. Biomaterials 34:1613–1623CrossRefPubMedGoogle Scholar
  62. 62.
    Xu Z, Li J, Zhou H et al (2016) Morphological and swelling behavior of cellulose nanofiber (CNF)/poly (vinyl alcohol)(PVA) hydrogels: poly (ethylene glycol)(PEG) as porogen. RSC Adv 6(49):43626–43633CrossRefGoogle Scholar
  63. 63.
    Thakur A, Wanchoo R, Singh P (2012) Hydrogels of poly (acrylamide-co-acrylic acid): in vitro study on release of gentamicin sulfate. Chem Biochem Eng Q 25:471–482Google Scholar
  64. 64.
    Gil MS, Thambi T, Phan VG et al (2017) Injectable hydrogel-incorporated cancer cell-specific cisplatin releasing nanogels for targeted drug delivery. J Mater Chem B 5:7140–7152CrossRefGoogle Scholar
  65. 65.
    Quagliariello V, Armenia E, Aurilio C et al (2016) New treatment of medullary and papillary human thyroid cancer: biological effects of hyaluronic acid hydrogel loaded with quercetin alone or in combination to an inhibitor of aurora kinase. J Cell Physiol 23:1784–1795CrossRefGoogle Scholar
  66. 66.
    Zhang H, Tian Y, Zhu Z et al (2016) Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation. Sci Rep 26:6.  https://doi.org/10.1038/srep26546 CrossRefGoogle Scholar
  67. 67.
    Sadzuka Y, Nagamine M, Toyooka T et al (2012) Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin. Int J Pharm 432:42–49CrossRefPubMedGoogle Scholar
  68. 68.
    Mohajeri M, Sahebkar A (2018) Protective effects of curcumin against doxorubicin-induced toxicity and resistance: a review. Crit Rev Oncol Hematol 122:30–51CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Biological ScienceNorth-West UniversityMmabathoSouth Africa
  2. 2.Department of ChemistryUniversity of Fort HareAliceSouth Africa
  3. 3.Institute of Nano Engineering Research (INER) and Department of Chemical, Metallurgical and Materials EngineeringTshwane University of TechnologyPretoriaSouth Africa
  4. 4.CSIR Biosciences, CSIRPretoriaSouth Africa
  5. 5.DST/CSIR National Centre for Nanostructured MaterialsCouncil for Scientific and Industrial ResearchPretoriaSouth Africa
  6. 6.Department of Applied ChemistryUniversity of JohannesburgDoornfontein, JohannesburgSouth Africa
  7. 7.Department of ChemistryUniversity of ZululandKwaDlangezwaSouth Africa

Personalised recommendations